NCT04853056

Brief Summary

Studies evaluating VR are quite insufficient. In the study we determined in the emergency room between the ages of 4-10, cold vibration and virtual reality will be compared, and the success of the first attempt, pain, fear and anxiety will be evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Dec 2020

Shorter than P25 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 14, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 16, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 21, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 14, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 14, 2021

Completed
Last Updated

February 10, 2022

Status Verified

February 1, 2022

Enrollment Period

6 months

First QC Date

April 16, 2021

Last Update Submit

February 9, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Pain assesed by Wong-Baker FACES

    Wong-Baker FACES (WB-FACES) Pain Rating Scale used. This scale uses in children aged 3 and older to rate pain severity. This numeric rating scale ranges from 0 to 10. Faces show emotions from smiling (0 = very happy/ no pain) to crying (10 = hurts worst).

    during the procedure

  • Anxiety assesed by Children Anxiety Meter-State

    The Children's Anxiety Meter (CAM-S). The Children's Anxiety Meter assesses children's anxiety and uses before medical procedures. This scale is drawn like a thermometer with a bulb at the bottom and also includes horizontal lines at intervals going up to the top (0-10). This scale ranges from 0 to 10. Higher values represent higher anxiety

    during the procedure

  • Fear assesed by Child Fear Scale

    The Child Fear Scale (CFS). The Child Fear Scale will use.This one-item scale measures procedure-related fear in children, consists of five sex-neutral faces, ranges from 0 (no fear) to extreme fear. This rating scale ranges from 0 to 4. It ranges from a no fear (neutral) face (0) on the far left to a face showing extreme fear on the far right. Higher scores mean a worse outcome. The rater responds indicates the level of fear. It can be used during the procedure for children aged 5-10 years.

    during the procedure

Secondary Outcomes (1)

  • Emotional Appearance Scale for Children

    Baseline (before the procedure)

Study Arms (3)

Virtual Reality Group

EXPERIMENTAL

watching the application by wearing virtual glasses to the child during the peripheral IV line insertion

Device: virtual reality

Cold Vibration Group

EXPERIMENTAL

Buzzy, connecting and operating 5 cm above the area to be inserted peripheral IV line

Device: Cold vibration

Control group

NO INTERVENTION

Standart care

Interventions

wearing virtual reality glasses

Also known as: distraction methods
Virtual Reality Group

Buzzy

Also known as: distraction methods
Cold Vibration Group

Eligibility Criteria

Age4 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children between the ages of 4-10
  • The child agrees to voluntarily participate in the study.
  • Parents agree to voluntarily participate in the study
  • Obtaining consent form from the child and parent

You may not qualify if:

  • \- The child with physical and psychological deficit to prevent him from wearing the glasses to be worn on his head so that he can watch virtual reality.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gülçin Özalp Gerçeker

Izmir, 35100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

PainAnxiety Disorders

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Gülçin Özalp Gerçeker

    RN, PhD, Assoc. Prof.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

April 16, 2021

First Posted

April 21, 2021

Study Start

December 14, 2020

Primary Completion

June 14, 2021

Study Completion

July 14, 2021

Last Updated

February 10, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations